Featured Research

from universities, journals, and other organizations

Develop after-sex contraceptive pill for routine use, urge researchers: Political opposition biggest hurdle

Date:
September 24, 2013
Source:
British Medical Journal
Summary:
A contraceptive pill that could be routinely used after, rather than before, sex and fertilization is probably scientifically feasible and would probably be welcomed by many women, say researchers.

A contraceptive pill that could be routinely used after, rather than before, sex and fertilisation is probably scientifically feasible and would probably be welcomed by many women.
Credit: Alliance / Fotolia

A contraceptive pill that could be routinely used after, rather than before, sex and fertilisation is probably scientifically feasible and would probably be welcomed by many women, say researchers in the Journal of Family Planning and Reproductive Health Care.

But the biggest hurdle impeding its development is likely to be political opposition, they suggest -- despite the fact that some current contraceptive methods, such as intrauterine devices (IUDs), can sometimes prevent pregnancy even after fertilisation.

There would be many advantages to routine "post-fertilisation" contraception -- as distinct from emergency contraception that has to be used within 72 hours -- write the US and Swedish specialists in reproductive health, public health, and economics.

For one, this method could be used for far longer after sex than emergency contraception, so would serve a much wider number of women than are currently able to access emergency contraception and use it within the defined time window.

It would also be more convenient, offering the potential to be used just once in the monthly menstrual cycle, no matter how many times a woman had had sex before taking it, or even when a period had just been missed.

"Importantly, post-fertilisation methods would eliminate the conceptual and logistical challenge of needing to obtain and initiate contraception before having sex, which can be daunting for both women and men," write the authors.

There would, of course, be technical hurdles to overcome, they acknowledge, as it's not clear whether some currently available drugs that can disrupt pregnancy either before or after implantation would work as effectively if used in this way.

But there are other promising compounds and the pharmaceutical know-how to develop them, confirm the authors. "Multidisciplinary research may be needed to define the best option, but given our rapidly increasing understanding of reproductive physiology, ultimate success seems likely," they say.

Political opposition is likely to pose a far greater challenge, they emphasise, as both the UK and US governments define the start of pregnancy as implantation of the fertilised egg, and interrupting this afterwards "is abortion by any definition," they write.

But abortion is legal in many countries and widely accepted by the public worldwide. And international data point to the greater safety of legal abortion the earlier it is carried out, they point out.

"Research from diverse settings has found that many women view medical abortion methods, particularly when used at home, as more natural and more compatible with their religious or ethical views than clinic or hospital based surgical procedures," they write.

Survey evidence suggests that women back the idea of post-fertilisation contraception; all that's lacking are "intrepid" funders who would be willing to kick-start the research, say the authors.

"To meet the challenges of our increasingly complicated world, women deserve all possible options for controlling and preserving their reproductive health and lives," they conclude.

In an accompanying podcast, lead author Elizabeth Raymond, senior medical associate at Gynuity Health Projects in New York, acknowledges the need to win over policy makers. Specialists working in family planning have their part to play, she suggests.

"We need to stop extolling pre-fertilisation contraception as a good thing, because it implies that something that works after fertilisation is bad. We have to stop doing that," she says.

"[Post-fertilisation] contraception doesn't have to be acceptable to every woman," she adds. "No method is acceptable to every woman now."


Story Source:

The above story is based on materials provided by British Medical Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. G. Raymond, F. Coeytaux, K. Gemzell-Danielsson, K. Moore, J. Trussell, B. Winikoff. Embracing post-fertilisation methods of family planning: a call to action. Journal of Family Planning and Reproductive Health Care, 2013; 39 (4): 244 DOI: 10.1136/jfprhc-2013-100702

Cite This Page:

British Medical Journal. "Develop after-sex contraceptive pill for routine use, urge researchers: Political opposition biggest hurdle." ScienceDaily. ScienceDaily, 24 September 2013. <www.sciencedaily.com/releases/2013/09/130924110057.htm>.
British Medical Journal. (2013, September 24). Develop after-sex contraceptive pill for routine use, urge researchers: Political opposition biggest hurdle. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130924110057.htm
British Medical Journal. "Develop after-sex contraceptive pill for routine use, urge researchers: Political opposition biggest hurdle." ScienceDaily. www.sciencedaily.com/releases/2013/09/130924110057.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins